4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient's interest to do so, with regard to the quality, safety, and efficacy of care, and only …

or therapeutic medical strategies. However, the ESC Guidelines do not override in any way
whatsoever the individual responsibility of health professionals to make appropriate and …

Risk stratification scheme. Risk stratification aiming at assessing the risk of VAs and SCD in
patients with MVP, involving two phases based on the clinical and imaging context and the …

This international multidisciplinary document intends to provide clinicians with evidence-
based practical patient-centered recommendations for evaluating patients and decedents …

Despite advancements in prevention and treatment, sudden cardiac death (SCD) remains a
leading cause of mortality and is responsible for approximately half of all deaths from …

The recommendations listed in this clinical practice guideline are, whenever possible,
evidence-based. An initial extensive evidence review, which included literature derived from …

Background Mitral valve prolapse (MVP) is often considered benign but recent suggestion of
an arrhythmic MVP (AMVP) form remains incompletely defined and uncertain. Objectives …

Background: Mitral annulus disjunction (MAD) is an abnormal atrial displacement of the
mitral valve leaflet hinge point. MAD has been associated with mitral valve prolapse (MVP) …

Despite major advancements in cardiovascular medicine, sudden cardiac death (SCD)
continues to be an enormous medical and societal challenge, claiming millions of lives …

Ventricular arrhythmias are an important cause of morbidity and mortality and come in a
variety of forms, from single premature ventricular complexes to sustained ventricular …